EW vs TBRG · P/E 47, rev $3.39B vs P/E 90, rev $342.6M
Edwards Lifesciences Corp (EW) versus TruBridge Inc. (TBRG) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
TruBridge Inc. (TBRG) is a health information services company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TBRG revenue for 2024-12-31 was $342.6M. Net income was -$20.4M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. TBRG currently screens at market cap $391.6M and trailing P/E 90.0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TBRG currently screens at market cap $391.6M and trailing P/E 90.0.
Not investment advice. Open the EW and TBRG stock pages for the full models.
Not investment advice.